In addition, trials on human and mice showed GLP-1 receptor agonists benefits in heart failure, endothelial lining and,myocardial ischemia.First, heart failure clinical trials on human showed at New York Heart Association involved diabetic patients with stage 3-4 heart failure better response with Glp-1 continuous infusion over 12 weeks duration in the form of better left ventricular ejection fraction and 6 minute walk over 48 hours trial of GLP-1 infusion in nondiabetic patients with stage 2-3 heart failure
[00:02:13] Ben Greenfield: Well, thank you so much for having me
namely genetics issues, the sun, and hormone activities
These agents have demonstrated robust efficacy in modulating metabolic dysfunctions central to MASLD progression, positioning them as a cornerstone in contemporary therapeutic strategies
[DOI] [PubMed] [Google Scholar] Moeinian M., Abdolghaffari A.H., Nikfar S., Momtaz S., Abdollahi M